Skip to main content
Cara Therapeutics, Inc. (CARA)
NASDAQ: CARA · IEX Real-Time Price · USD
0.345
-0.003 (-0.72%)
At close: Jul 19, 2024, 4:00 PM
0.339
-0.005 (-1.51%)
Pre-market: Jul 22, 2024, 7:00 AM EDT

Cara Therapeutics Revenue

Cara Therapeutics had revenue of $16.94M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $2.14M. In the year 2023, Cara Therapeutics had annual revenue of $20.97M.

Revenue (ttm)
$16.94M
Revenue Growth
-60.83%
P/S Ratio
1.11
Revenue / Employee
$307,964
Employees
55
Market Cap
18.84M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202320.97M-20.90M-49.92%
Dec 31, 202241.87M18.84M81.81%
Dec 31, 202123.03M-112.05M-82.95%
Dec 31, 2020135.08M115.20M579.28%
Dec 31, 201919.89M6.42M47.64%
Dec 31, 201813.47M12.56M1,378.49%
Dec 31, 2017911.00K825.00K959.30%
Dec 31, 201686.00K-3.72M-97.74%
Dec 31, 20153.80M626.00K19.70%
Dec 31, 20143.18M-8.79M-73.45%
Dec 31, 201311.96M10.77M905.38%
Dec 31, 20121.19M--
Dec 31, 20110--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MEI Pharma 66.75M
Aspira Women's Health 8.99M
Synlogic 3.21M
NeurAxis 2.30M
Bullfrog AI 65.00K
iBio, Inc. 50.00K
GlycoMimetics 10.00K
Revenue Rankings

CARA News

More News